Icon

VICTOZA (nda022341)- (18MG/3ML (6MG/ML))

LIRAGLUTIDE NOVO NORDISK INC
18MG/3ML (6MG/ML)
Yes No
2037-Jul-09 2015-Jan-25
None None
None No
VICTOZA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated: • as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2 diabetes mellitus. • to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease
1 0 0
Total Other Developers 39
Drugs with Suitability No
18MG/3ML (6MG/ML) ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.